The Non-Inflammasome NLRs in Immunity and Host defense
The Non-Inflammasome NLRs in Immunity and Host defense
批准号:
9243972
负责人:
Thirumala-Devi Kanneganti
金额:
$44.88万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-03-15 至 2021-02-28
关键词:
AddressAutoimmune DiseasesAutoimmune ProcessAwardBacterial InfectionsBiochemicalCASP1 geneCellsCellular StressCommunicable DiseasesComplexDataDiseaseEmployee StrikesFRAP1 geneFamilyGenerationsGenesGenetic PolymorphismGrantHereditary DiseaseHost DefenseHumanIRAK1 geneImmuneImmune System DiseasesImmune responseImmune signalingImmunityImmunologic ReceptorsImmunologyImmunosuppressionIn VitroInfectionInflammasomeInflammationInflammatoryInfluenza A virusInterleukin-1 betaInterleukin-18LeadLinkMAP Kinase GeneMalignant NeoplasmsMediatingMissense MutationModelingMolecularMorbidity - disease rateMusMutationNational Institute of Allergy and Infectious DiseaseNatural ImmunityOutcomePathologyPathway interactionsPatientsPeptidoglycanPhysiologicalPlayPredispositionProto-Oncogene Proteins c-aktRecruitment ActivityRegulationRegulatory PathwayResearchRoleSignal PathwaySignal TransductionT-LymphocyteTestingTherapeuticToll-like receptorsUbiquitinVaccinesVirus DiseasesWorkadaptive immune responseadaptive immunityautoinflammatorybasecancer cellcytokinedesignexhaustionexperimental studyhuman diseaseimmunopathologyimmunoregulationimprovedin vivointerestmacrophagemembermortalitymulticatalytic endopeptidase complexnovelpathogenprematureprotein complexpublic health relevancereceptorresponsesensor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): NOD-like receptors (NLRs) are a family of intracellular sensor molecules involved in the regulation of inflammatory signaling in response to infection and cellular stress. Recent studies have revealed pivotal roles for NLR-mediated inflammation in a spectrum of diverse human autoimmune and inflammatory disorders. The vast majority of NLRs to date have been defined as activators of inflammatory signaling in innate immune cells. For instance, the prototypical NLR members, NOD1 and NOD2, initiate proinflammatory NF-κB and MAPK signaling in response to their direct recognition of bacterial peptidoglycan fragments. Multiple NLRs have also been described to promote the activation and secretion of the proinflammatory cytokines IL-1β and IL-18 by coordinating the assembly of the inflammasome complex. In contrast, some NLRs, such as NLRP6, NLRP12, NLRC3 and NLRX1, negatively regulate inflammatory signaling. However, the cellular and molecular mechanisms that direct the suppression of inflammation by this new class of inhibitory NLRs are not known. Missense mutations in NLRP12 are associated with inflammatory diseases in humans, but the biochemical mechanisms and pathways underlying these pathologies remain unclear. Recent work from our lab demonstrates that NLRP12 functions as a key negative regulator of NF-κB signaling. Importantly, inflammation and immunopathology are not exclusively restricted to inflammatory and autoimmune diseases. The dysregulation of innate and adaptive immunity can also result in striking differences with regard to morbidity and mortality during infectious disease. In this regard, NLRP12's role in viral infection and generation of adaptive immune responses has not been investigated. Therefore, this project is highly significant, as it will lead to the identification of key immune mechanisms involved in host
defense and inflammatory control mechanisms dependent on NLRP12 that regulate inflammation. We will examine these mechanisms through the use of influenza A virus.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting innate immune pathways, and inflammatory cell death in cytokine-mediated diseases
-
批准号:10622511
-
项目类别:
-
资助金额:$76.38万
-
财政年份:2021
-
负责人:Thirumala-Devi Kanneganti
-
依托单位:
Regulation of lung inflammatory and antiviral responses during coronavirus infection
-
批准号:10631757
-
项目类别:
-
资助金额:$39.34万
-
财政年份:2021
-
负责人:Thirumala-Devi Kanneganti
-
依托单位:
Targeting innate immune pathways, and inflammatory cell death in cytokine-mediated diseases
-
批准号:10428652
-
项目类别:
-
资助金额:$76.38万
-
财政年份:2021
-
负责人:Thirumala-Devi Kanneganti
-
依托单位:
Targeting innate immune pathways, and inflammatory cell death in cytokine-mediated diseases
-
批准号:10311802
-
项目类别:
-
资助金额:$76.38万
-
财政年份:2021
-
负责人:Thirumala-Devi Kanneganti
-
依托单位:
Innate immune sensors, inflammasomes, and inflammasome-mediated processes in cancer
-
批准号:10633206
-
项目类别:
-
资助金额:$105.55万
-
财政年份:2020
-
负责人:Thirumala-Devi Kanneganti
-
依托单位:
Innate immune sensors, inflammasomes, and inflammasome-mediated processes in cancer
-
批准号:10220912
-
项目类别:
-
资助金额:$107.7万
-
财政年份:2020
-
负责人:Thirumala-Devi Kanneganti
-
依托单位:
Innate immune sensors, inflammasomes, and inflammasome-mediated processes in cancer
-
批准号:10442693
-
项目类别:
-
资助金额:$100.88万
-
财政年份:2020
-
负责人:Thirumala-Devi Kanneganti
-
依托单位:
Innate immune signaling and stress response
-
批准号:9901240
-
项目类别:
-
资助金额:$53.85万
-
财政年份:2016
-
负责人:Thirumala-Devi Kanneganti
-
依托单位:
Innate immune signaling and stress response
-
批准号:10327667
-
项目类别:
-
资助金额:$53.85万
-
财政年份:2016
-
负责人:Thirumala-Devi Kanneganti
-
依托单位:
Innate immune signaling and stress response
-
批准号:10574531
-
项目类别:
-
资助金额:$53.85万
-
财政年份:2016
-
负责人:Thirumala-Devi Kanneganti
-
依托单位:
Inflammatory Caspases in Innate Immunity and Inflammation
-
批准号:9127673
-
项目类别:
-
资助金额:$44.88万
-
财政年份:2012
-
负责人:Thirumala-Devi Kanneganti
-
依托单位:
NLR signaling in colitis and colorectal tumorigenesis
-
批准号:8831610
-
项目类别:
-
资助金额:$36.31万
-
财政年份:2012
-
负责人:Thirumala-Devi Kanneganti
-
依托单位:
Inflammatory Caspases in Innate Immunity and Inflammation
-
批准号:8827667
-
项目类别:
-
资助金额:$43.75万
-
财政年份:2012
-
负责人:Thirumala-Devi Kanneganti
-
依托单位:
Inflammatory Caspases in Innate Immunity and Inflammation
-
批准号:9912091
-
项目类别:
-
资助金额:$44.88万
-
财政年份:2012
-
负责人:Thirumala-Devi Kanneganti
-
依托单位:
Inflammatory Caspases in Innate Immunity and Inflammation
-
批准号:10295212
-
项目类别:
-
资助金额:$45.5万
-
财政年份:2012
-
负责人:Thirumala-Devi Kanneganti
-
依托单位:
Innate signaling pathways in colitis and colorectal tumorigenesis
-
批准号:9120535
-
项目类别:
-
资助金额:$42.63万
-
财政年份:2012
-
负责人:Thirumala-Devi Kanneganti
-
依托单位:
Inflammatory Caspases in Innate Immunity and Inflammation
-
批准号:8365332
-
项目类别:
-
资助金额:$43.75万
-
财政年份:2012
-
负责人:Thirumala-Devi Kanneganti
-
依托单位:
NLR signaling in colitis and colorectal tumorigenesis
-
批准号:8373063
-
项目类别:
-
资助金额:$36.31万
-
财政年份:2012
-
负责人:Thirumala-Devi Kanneganti
-
依托单位:
Innate signaling pathways in colitis and colorectal tumorigenesis
-
批准号:9892953
-
项目类别:
-
资助金额:$42.63万
-
财政年份:2012
-
负责人:Thirumala-Devi Kanneganti
-
依托单位:
NLR signaling in colitis and colorectal tumorigenesis
-
批准号:8507633
-
项目类别:
-
资助金额:$34.13万
-
财政年份:2012
-
负责人:Thirumala-Devi Kanneganti
-
依托单位:
国内基金
海外基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
-
批准号:31171277
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:Christine Nardini
-
依托单位: